These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Bone remodeling, normal and abnormal: a biological basis for the understanding of cancer-related bone disease and its treatment. Parfitt AM Can J Oncol; 1995 Dec; 5 Suppl 1():1-10. PubMed ID: 8853518 [TBL] [Abstract][Full Text] [Related]
6. [Pathophysiology of bone metastases in urologic carcinomas]. Sauer G; Barth TF; Möller P Urologe A; 2007 Aug; 46(8):888-90. PubMed ID: 17632696 [TBL] [Abstract][Full Text] [Related]
7. Research on bone metastases quickens its pace. Ziegler J J Natl Cancer Inst; 1997 Jun; 89(12):841-3. PubMed ID: 9196248 [No Abstract] [Full Text] [Related]
8. Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases. de Vernejoul MC Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):119S-123S. PubMed ID: 9273953 [No Abstract] [Full Text] [Related]
9. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma. Bataille R; Chappard D; Klein B Int J Clin Lab Res; 1992; 21(4):283-7. PubMed ID: 1591381 [TBL] [Abstract][Full Text] [Related]
10. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein. Wysolmerski JJ; Broadus AE Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376 [TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein in hypercalcemia associated with hematological malignancy. Firkin F; Schneider H; Grill V Leuk Lymphoma; 1998 May; 29(5-6):499-506. PubMed ID: 9643563 [TBL] [Abstract][Full Text] [Related]
12. Malignant tumors and bone. Chapman B CAP Today; 1997 Apr; 11(4):42-4. PubMed ID: 10174224 [No Abstract] [Full Text] [Related]
14. Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo. Chantry AD; Heath D; Mulivor AW; Pearsall S; Baud'huin M; Coulton L; Evans H; Abdul N; Werner ED; Bouxsein ML; Key ML; Seehra J; Arnett TR; Vanderkerken K; Croucher P J Bone Miner Res; 2010 Dec; 25(12):2633-46. PubMed ID: 20533325 [TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia and bone metastases in breast cancer. Warrell RP Curr Opin Oncol; 1990 Dec; 2(6):1097-103. PubMed ID: 2151596 [No Abstract] [Full Text] [Related]
16. Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma. Liu H; Liu Z; Du J; He J; Lin P; Amini B; Starbuck MW; Novane N; Shah JJ; Davis RE; Hou J; Gagel RF; Yang J Sci Transl Med; 2016 Aug; 8(353):353ra113. PubMed ID: 27559096 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of bone lesions in multiple myeloma and lymphoma. Roodman GD Cancer; 1997 Oct; 80(8 Suppl):1557-63. PubMed ID: 9362422 [TBL] [Abstract][Full Text] [Related]
18. The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms. Mundy GR; Ibbotson KJ; D'Souza SM; Simpson EL; Jacobs JW; Martin TJ N Engl J Med; 1984 Jun; 310(26):1718-27. PubMed ID: 6328302 [No Abstract] [Full Text] [Related]
19. Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts. Evely RS; Bonomo A; Schneider HG; Moseley JM; Gallagher J; Martin TJ J Bone Miner Res; 1991 Jan; 6(1):85-93. PubMed ID: 2048435 [TBL] [Abstract][Full Text] [Related]
20. [Progress in diagnosis and therapy: Hypercalcemia due to multiple myeloma and wide-spread neoplastic bone metastasis]. Abe M Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):675-80. PubMed ID: 17506303 [No Abstract] [Full Text] [Related] [Next] [New Search]